Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ACON Aclarion
0.6500.0000.00%
Trading Session
01/31 11:26 ET
High
0.650
Open
0.650
Turnover
415.00
Low
0.650
Pre Close
0.650
Volume
635.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Press Release: Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisor
Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisor Director of Endoscopic Spine Surgery at the University of Miami Broomfield, CO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMed
Aclarion, Inc. (NASDAQ:ACON) Short Interest Down 7.8% in December
Aclarion, Inc. (NASDAQ:ACON – Get Rating) was the recipient of a large decrease in short interest during the month of December. As of December 30th, there was short interest totalling 51,000 shares,
Aclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon Advisor
Broomfield, CO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary
Aclarion to Present at the Jan 26th Virtual Investor Summit Microcap Event
Broomfield, Colorado--(Newsfile Corp. - January 17, 2023) - Aclarion, Inc., (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Broadwind Inc (NASDAQ:BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine manufactu
On December 20, 2022, Aclarion Received A Written Notice From Nasdaq For Failing To Comply With The Minimum Bid Price Requirement
On December 20, 2022, Aclarion Received A Written Notice From Nasdaq For Failing To Comply With The Minimum Bid Price Requirement
12 Health Care Stocks Moving In Friday's Intraday Session
GainersImmuron (NASDAQ:IMRN) shares increased by 37.9% to $2.22 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 17.1 million shares, making up 288523.4% of it
Press Release: Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor
Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor Broomfield, CO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., ("Aclarion" or the "Company") (Nasd
Press Release: Aclarion's Key Opinion Leader Program Adds Fifth Surgeon Advisor With Addition of Eric Potts, MD
Aclarion's Key Opinion Leader Program Adds Fifth Surgeon Advisor with Addition of Eric Potts, MD Development of this program supports Aclarion's commitment to lead with strong clinical evidence and e
Aclarion Announces Uribe Will Advise Company as KOL
Company Overview
More
Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.
CEO： Mr. Brent Ness
Market： NASDAQ
Listing Date： 04/22/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet